Budecort Respules 0.5 mg per 2ml delivers budesonide directly to the bronchial airways, achieving local anti-inflammatory effects with significantly lower systemic steroid exposure compared to oral corticosteroids. The small amount of budesonide absorbed into the bloodstream is metabolised rapidly by the liver, reducing risks of adrenal suppression, bone density loss, and weight gain associated with long-term oral steroid use. This makes nebulised budesonide a preferred choice for sustained asthma maintenance. Cipla manufactures these unit-dose 2 mL respules. Prescription required. Not suitable for acute asthma rescue therapy.
Purchase now:
https://edpillsforever.com/ ...